Isabella Wanderley de Queiroga Evangelista
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabella Wanderley de Queiroga Evangelista has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Cecília Neta Alves Pegado Gomes
Nephrology Clinic, Lauro Wanderley University Hospital, Federal University of Paraiba, Joao Pessoa, Brazil
4 shared publications - Darlene Camati Persuhn
Department of Molecular Biology, Center for Exact and Natural Sciences, Federal University of Paraíba—UFPB, João Pessoa 58051-900, PB, Brazil
4 shared publications - João Modesto Filho
Department of Internal Medicine, Federal University of Paraiba, Joao Pessoa, Brazil
4 shared publications - Mayara Karla dos Santos Nunes
Post-Graduation Program in Cellular and Molecular Biology, Federal University of Paraiba, Joao Pessoa, Brazil
4 shared publications - Naila Francis Paulo de Oliveira
Graduate Program in Dentistry, Health Sciences Center, Federal University of Paraíba—UFPB, João Pessoa 58051-900, PB, Brazil
4 shared publications - Rayner Anderson Ferreira Do Nascimento
Faculty Mauricio of Nassau, Joao Pessoa, Brazil
4 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 85
Kit de triagem oftalmológica na Atenção Primária como ferramenta de prevenção da cegueira e baixa visão infantil
RESUMO Objetivo: Desenvolver e descrever o kit oftalmológico de triagem para uso por médicos generalistas na Atenção Primária à Saúde, visando à triagem de crianças de zero a 10 anos e à prevenção da ambliopia. Métodos: Estudo metodológico em quatro fases: revisão integrativa da literatura; planejamento com matriz SWOT; construção dos componentes do kit oftalmológico de triagem; e refinamento com avaliação de funcionalidade, validade de conteúdo, aplicabilidade e limitações. Resultados: O kit oftalmológico de triagem reuniu: manual de orientação médica [...] RESUMO Objetivo: Desenvolver e descrever o kit oftalmológico de triagem para uso por médicos generalistas na Atenção Primária à Saúde, visando à triagem de crianças de zero a 10 anos e à prevenção da ambliopia. Métodos: Estudo metodológico em quatro fases: revisão integrativa da literatura; planejamento com matriz SWOT; construção dos componentes do kit oftalmológico de triagem; e refinamento com avaliação de funcionalidade, validade de conteúdo, aplicabilidade e limitações. Resultados: O kit oftalmológico de triagem reuniu: manual de orientação médica
- 14 October 2026
- Published by Revista Brasileira de Oftalmologia in Revista Brasileira de Oftalmologia
- Vol. 85
Open AccessKit de triagem oftalmológica na Atenção Primária como ferramenta de prevenção da cegueira e baixa visão infantil
RESUMO Objetivo: Desenvolver e descrever o kit oftalmológico de triagem para uso por médicos generalistas na Atenção Primária à Saúde, visando à triagem de crianças de zero a 10 anos e à prevenção da ambliopia. Métodos: Estudo metodológico em quatro fases: revisão integrativa da literatura; planejamento com matriz SWOT; construção dos componentes do kit oftalmológico de triagem; e refinamento com avaliação de funcionalidade, validade de conteúdo, aplicabilidade e limitações. Resultados: O kit oftalmológico de triagem reuniu: manual de orientação médica [...] RESUMO Objetivo: Desenvolver e descrever o kit oftalmológico de triagem para uso por médicos generalistas na Atenção Primária à Saúde, visando à triagem de crianças de zero a 10 anos e à prevenção da ambliopia. Métodos: Estudo metodológico em quatro fases: revisão integrativa da literatura; planejamento com matriz SWOT; construção dos componentes do kit oftalmológico de triagem; e refinamento com avaliação de funcionalidade, validade de conteúdo, aplicabilidade e limitações. Resultados: O kit oftalmológico de triagem reuniu: manual de orientação médica
- Open Access
- 1 July 2021
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 17 (6) , 8-16
Methylation Profile of miR-9-1 and miR-9-1/-9-3 as Potential Biomarkers of Diabetic Retinopathy
Aims: Analysis of the relationship between the methylation profile of miR-9-1 or miRs -9-1 / -9-3 and diabetic retinopathy. Background: Diabetic Retinopathy (DR) is a frequent complication of Diabetes mellitus and it has a decisive impact on the quality of life, as it is one of the biggest causes of blindness in the adult population. Levels of microRNA-9 have been shown to be related to diabetes but little is known about its involvement with DR in humans. Objective: To analyze the relationship between the methylation profile of miR-9-1 or miRs -9-1/-9-3 and DR. Methods: 103 patients diagnosed with diabetes for 5 to 10 years were analyzed. The data were categorized according to clinical, biochemical, lifestyle and anthropometric parameters. DNA extracted from leukocyte samples was used to determine the methylation profile of miRs-9-1 and -9-3 using a specific methylation PCR assay. Results: miR-9-1 methylation was related to diabetic retinopathy, indicating that methylation of this miR increases the chances of presenting retinopathy up to 5 times. In our analyses, diabetics with lower levels of creatinine and CRP showed significant reductions (99% and 97%) in presenting DR. Methylation of both miRs-9-1 and 9-3 methylated increases the chances of presenting DR by 8 times; in addition, a sedentary lifestyle can increase the risk for the same complication by up to 6 times. Conclusion: Our results suggest that both methylation of miR-9-1 and e miRs-9-1 / 9-3 favors DR in patients with diabetes in a period of 5 to 10 years of diagnosis.
- 1 July 2021
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 17 (6) , 8-16
Open AccessMethylation Profile of miR-9-1 and miR-9-1/-9-3 as Potential Biomarkers of Diabetic Retinopathy
Aims: Analysis of the relationship between the methylation profile of miR-9-1 or miRs -9-1 / -9-3 and diabetic retinopathy. Background: Diabetic Retinopathy (DR) is a frequent complication of Diabetes mellitus and it has a decisive impact on the quality of life, as it is one of the biggest causes of blindness in the adult population. Levels of microRNA-9 have been shown to be related to diabetes but little is known about its involvement with DR in humans. Objective: To analyze the relationship between the methylation profile of miR-9-1 or miRs -9-1/-9-3 and DR. Methods: 103 patients diagnosed with diabetes for 5 to 10 years were analyzed. The data were categorized according to clinical, biochemical, lifestyle and anthropometric parameters. DNA extracted from leukocyte samples was used to determine the methylation profile of miRs-9-1 and -9-3 using a specific methylation PCR assay. Results: miR-9-1 methylation was related to diabetic retinopathy, indicating that methylation of this miR increases the chances of presenting retinopathy up to 5 times. In our analyses, diabetics with lower levels of creatinine and CRP showed significant reductions (99% and 97%) in presenting DR. Methylation of both miRs-9-1 and 9-3 methylated increases the chances of presenting DR by 8 times; in addition, a sedentary lifestyle can increase the risk for the same complication by up to 6 times. Conclusion: Our results suggest that both methylation of miR-9-1 and e miRs-9-1 / 9-3 favors DR in patients with diabetes in a period of 5 to 10 years of diagnosis.
- Open Access
- 15 January 2019
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 11 (1) , 4
The MTHFR promoter hypermethylation pattern associated with the A1298C polymorphism influences lipid parameters and glycemic control in diabetic patients
Polymorphisms in the gene encoding methylenetetrahydrofolate reductase (MTHFR) have been investigated as risk factors for microvascular complications of diabetes; however, simultaneous analysis of these polymorphisms and the methylation pattern of the gene has never been conducted. The objective of the present study was to evaluate the simultaneous relationship between MTHFR methylation and MTHFR C6TT7 and A1298C polymorphisms with metabolic, inflammatory and oxidative stress parameters related to microvascular complications, diabetic retinopathy (DR) and diabetic nephropathy (DN) in diabetic patients. A total of 107 patients who were diagnosed in the previous 5 to 10 years were recruited and divided into groups with complications (DR and/or DN) or without complications. Methylation analysis of the gene promoter was conducted using the MSP technique, and analysis of the A1298C and C677T polymorphisms was conducted using the restriction fragment length polymorphism (RFLP) assay. Microalbuminuria was determined using urine samples, and other analytes of interest were determined in blood samples using commercial kits. The Mann–Whitney and Chi square statistical tests were used with significance considered at p < 0.05. Subjects with a hypermethylated profile and the 1298AA genotype showed the highest levels of blood glucose (p = 0.03), total cholesterol (p = 0.0001) and LDL cholesterol (p = 0.0006). The same profile was associated with higher levels of HbA1c (p = 0.025), glycemia (p = 0.04) and total cholesterol (0.004) in the control group and total cholesterol (p = 0.005) and LDL cholesterol (p = 0.002) in the complications group. Serum creatinine was higher in subjects in the hypermethylated group with the genotype 677CC only in the control group (p = 0.0020). The methylated profile in presence of 677CC + 1298AA and the 677CT/TT +1298AA haplotypes showed higher levels of total cholesterol (p = 0.0024; 0.0031) and LDL cholesterol (p = 0.0060; 0.0125) than 1298AC/CC carriers. The fasting glycemia was higher in hypermethylated profile in the presence of 677CC/1298AA haplotype (p = 0.0077). The hypermethylated methylation profile associated with the 1298AA genotype appeared to be connected to higher values of glycemia, total cholesterol and LDL cholesterol.
- 15 January 2019
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 11 (1) , 4
Open AccessThe MTHFR promoter hypermethylation pattern associated with the A1298C polymorphism influences lipid parameters and glycemic control in diabetic patients
Polymorphisms in the gene encoding methylenetetrahydrofolate reductase (MTHFR) have been investigated as risk factors for microvascular complications of diabetes; however, simultaneous analysis of these polymorphisms and the methylation pattern of the gene has never been conducted. The objective of the present study was to evaluate the simultaneous relationship between MTHFR methylation and MTHFR C6TT7 and A1298C polymorphisms with metabolic, inflammatory and oxidative stress parameters related to microvascular complications, diabetic retinopathy (DR) and diabetic nephropathy (DN) in diabetic patients. A total of 107 patients who were diagnosed in the previous 5 to 10 years were recruited and divided into groups with complications (DR and/or DN) or without complications. Methylation analysis of the gene promoter was conducted using the MSP technique, and analysis of the A1298C and C677T polymorphisms was conducted using the restriction fragment length polymorphism (RFLP) assay. Microalbuminuria was determined using urine samples, and other analytes of interest were determined in blood samples using commercial kits. The Mann–Whitney and Chi square statistical tests were used with significance considered at p < 0.05. Subjects with a hypermethylated profile and the 1298AA genotype showed the highest levels of blood glucose (p = 0.03), total cholesterol (p = 0.0001) and LDL cholesterol (p = 0.0006). The same profile was associated with higher levels of HbA1c (p = 0.025), glycemia (p = 0.04) and total cholesterol (0.004) in the control group and total cholesterol (p = 0.005) and LDL cholesterol (p = 0.002) in the complications group. Serum creatinine was higher in subjects in the hypermethylated group with the genotype 677CC only in the control group (p = 0.0020). The methylated profile in presence of 677CC + 1298AA and the 677CT/TT +1298AA haplotypes showed higher levels of total cholesterol (p = 0.0024; 0.0031) and LDL cholesterol (p = 0.0060; 0.0125) than 1298AC/CC carriers. The fasting glycemia was higher in hypermethylated profile in the presence of 677CC/1298AA haplotype (p = 0.0077). The hypermethylated methylation profile associated with the 1298AA genotype appeared to be connected to higher values of glycemia, total cholesterol and LDL cholesterol.
- 1 June 2018
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 32 (6) , 593-601
Analysis of the DNA methylation profiles of miR-9-3, miR-34a, and miR-137 promoters in patients with diabetic retinopathy and nephropathy
- 1 June 2018
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 32 (6) , 593-601
Analysis of the DNA methylation profiles of miR-9-3, miR-34a, and miR-137 promoters in patients with diabetic retinopathy and nephropathy
- Open Access
- 18 October 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 84
Hypermethylation in the promoter of the MTHFR gene is associated with diabetic complications and biochemical indicators
DNA methylation is an epigenetic mechanism for regulating the transcription of many genes and has been linked to the development of various diseases. A promising gene to investigate is methylenetetrahydrofolate reductase (MTHFR), since the enzyme methylenetetrahydrofolate reductase (MTHFR) promotes methyl radical synthesis in the homocysteine cycle and can provide methyl groups for DNA methylation. In addition, several studies have correlated gene polymorphisms of this enzyme with a greater risk of diabetes, but little is known regarding the relationship between epigenetic changes in this gene and diabetes and its complications. The aim of this study was to investigate the relationship between methylation profile in the MTHFR gene promoter and biochemical, inflammatory and oxidative stress markers in individuals with type 2 diabetes (T2DM) who have been diagnosed for 5–10 years with or without diabetic retinopathy (DR) and nephropathy (DN). Specific PCR for methylation (MSP) was used to analyze MTHFR methylation profile in leucocytes DNA. Biochemical markers (glycemia, glycated hemoglobin, total cholesterol, LDL, HDL, triglycerides, serum creatinine), inflammatory markers (C-reactive protein and alpha-1 acid glycoprotein) and oxidative stress (total antioxidant and malonaldehyde) were determined in peripheric blood samples and microalbuminuria in 24 h urine samples. The X2 and Mann–Whitney statistical tests were performed and p < 0.05 were considered significant. The hypermethylated profile was most frequently observed in individuals with retinopathy (p < 0.01) and was associated with higher total cholesterol and LDL levels (p = 0.0046, 0.0267, respectively). Individuals with DN and hypermethylated profiles had higher levels of alpha-1 acid glycoprotein (p = 0.0080) and total antioxidant capacity (p = 0.0169) compared to subjects without complications. Hypermethylation in the promoter of the MTHFR gene is associated with the occurrence of DR and with biochemical, inflammatory and oxidative stress parameters in the context of chronic complications
- 18 October 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 84
Open AccessHypermethylation in the promoter of the MTHFR gene is associated with diabetic complications and biochemical indicators
DNA methylation is an epigenetic mechanism for regulating the transcription of many genes and has been linked to the development of various diseases. A promising gene to investigate is methylenetetrahydrofolate reductase (MTHFR), since the enzyme methylenetetrahydrofolate reductase (MTHFR) promotes methyl radical synthesis in the homocysteine cycle and can provide methyl groups for DNA methylation. In addition, several studies have correlated gene polymorphisms of this enzyme with a greater risk of diabetes, but little is known regarding the relationship between epigenetic changes in this gene and diabetes and its complications. The aim of this study was to investigate the relationship between methylation profile in the MTHFR gene promoter and biochemical, inflammatory and oxidative stress markers in individuals with type 2 diabetes (T2DM) who have been diagnosed for 5–10 years with or without diabetic retinopathy (DR) and nephropathy (DN). Specific PCR for methylation (MSP) was used to analyze MTHFR methylation profile in leucocytes DNA. Biochemical markers (glycemia, glycated hemoglobin, total cholesterol, LDL, HDL, triglycerides, serum creatinine), inflammatory markers (C-reactive protein and alpha-1 acid glycoprotein) and oxidative stress (total antioxidant and malonaldehyde) were determined in peripheric blood samples and microalbuminuria in 24 h urine samples. The X2 and Mann–Whitney statistical tests were performed and p < 0.05 were considered significant. The hypermethylated profile was most frequently observed in individuals with retinopathy (p < 0.01) and was associated with higher total cholesterol and LDL levels (p = 0.0046, 0.0267, respectively). Individuals with DN and hypermethylated profiles had higher levels of alpha-1 acid glycoprotein (p = 0.0080) and total antioxidant capacity (p = 0.0169) compared to subjects without complications. Hypermethylation in the promoter of the MTHFR gene is associated with the occurrence of DR and with biochemical, inflammatory and oxidative stress parameters in the context of chronic complications